|
1D5R
Crystal Structure of the PTEN Tumor Suppressor
Deposited 1999-10-11
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
7–285(279 aa)
Fragment:RESIDUES 7-353
Chain A
310–353(44 aa)
Fragment:RESIDUES 7-353
|
Mutation:RESIDUES 286-309 ARE REPLACED BY VAL
Mutation:RESIDUES 286-309 ARE REPLACED BY VAL
|
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;NA/K TARTRATE, 5% GLYCEROL, 100MM TRIS-CL, 10MM DTT, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.276
|
|
2KYL
Solution structure of MAST2-PDZ complexed with the C-terminus of PTEN
Deposited 2010-06-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
391–403(13 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;298 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient
NMR sample composition
0.6mM [U-100% 13C; U-100% 15N] PDZ-domain-1, 1.2mM PTEN-2, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
4O1V
SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer
Deposited 2013-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
354–368(15 aa)
Fragment:UNP residues 354-368
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;100 mM Tris, 100 mM sodium malonate, 36% PEG400, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.00 Å
R-free 0.221
|
|
5BZX
Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex
Deposited 2015-06-11
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309
|
VO4 VANADATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.50 Å
R-free 0.204
|
|
5BZX
Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex
Deposited 2015-06-11
|
Different construct
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309
|
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.50 Å
R-free 0.204
|
|
5BZX
Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex
Deposited 2015-06-11
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309
|
VO4 VANADATE ION × 1
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.50 Å
R-free 0.204
|
|
5BZX
Crystal structure of human phosphatase PTEN treated with a bisperoxovanadium complex
Deposited 2015-06-11
|
Different construct
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309
|
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrat, 7.5% glycerol
|
Resolution 2.50 Å
R-free 0.204
|
|
5BZZ
Crystal structure of human phosphatase PTEN in its reduced state
Deposited 2015-06-11
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309
|
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
|
Resolution 2.20 Å
R-free 0.221
|
|
5BZZ
Crystal structure of human phosphatase PTEN in its reduced state
Deposited 2015-06-11
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309
|
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
|
Resolution 2.20 Å
R-free 0.221
|
|
5BZZ
Crystal structure of human phosphatase PTEN in its reduced state
Deposited 2015-06-11
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309
|
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
|
Resolution 2.20 Å
R-free 0.221
|
|
5BZZ
Crystal structure of human phosphatase PTEN in its reduced state
Deposited 2015-06-11
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
14–351(338 aa)
Fragment:PTEN wt 7-353 delta 286-309
|
Mutation:Deletion 286-309
|
TLA L(+)-TARTARIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M MES pH 6.5, 1.25 M L-tartrate, 7.5% glycerol
|
Resolution 2.20 Å
R-free 0.221
|
|
7JUK
Crystal structure of PTEN with a tetra-phosphorylated tail (4p-crPTEN-13sp-T2, SDTTDSDPENEG)
Deposited 2020-08-19
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
7–285(279 aa)
Chain A
310–353(44 aa)
Chain A
378–390(13 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.2 M DL-malic acid
|
Resolution 3.15 Å
R-free 0.289
|
|
7JUL
Crystal structure of non phosphorylated PTEN (n-crPTEN-13sp-T1, SDTTDSDPENEG)
Deposited 2020-08-20
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
7–285(279 aa)
Chain A
310–353(44 aa)
Chain A
378–390(13 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293.15 K;1:1 volume of well solution: 100 mM Bis-Tris propane pH 7.0, 1.2 M DL-malic acid
|
Resolution 2.53 Å
R-free 0.234
|
|
7JVX
Crystal structure of PTEN (aa 7-353 followed by spacer TGGGSGGTGGGSGGTGGGCY ligated to peptide pSDpTpTDpSDPENEPFDED)
Deposited 2020-08-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–403(403 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;300 mM citrate
|
Resolution 3.20 Å
R-free 0.296
|
|
7PC7
The PDZ domain of SNTG1 complexed with the acetylated PDZ-binding motif of PTEN
Deposited 2021-08-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
394–403(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CA CALCIUM ION × 6
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M Tris 8.5, 22 % v/v PEG Smear Broad
|
Resolution 2.10 Å
R-free 0.218
|
|
7PC7
The PDZ domain of SNTG1 complexed with the acetylated PDZ-binding motif of PTEN
Deposited 2021-08-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
394–403(10 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CA CALCIUM ION × 6
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M Tris 8.5, 22 % v/v PEG Smear Broad
|
Resolution 2.10 Å
R-free 0.218
|
|
8X3S
Crystal structure of human WDR5 in complex with PTEN
Deposited 2023-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
115–148(34 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M lithium sulfate monohydrate, 0.1 M HEPES at pH 7.5, 25% w/v polyethylene glycol 3350
|
Resolution 1.87 Å
R-free 0.259
|